BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12914933)

  • 21. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.
    Sodhi A; Montaner S; Miyazaki H; Gutkind JS
    Biochem Biophys Res Commun; 2001 Sep; 287(1):292-300. PubMed ID: 11549290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
    Gao N; Nester RA; Sarkar MA
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK activation upon hypoxia: involvement in HIF-1 activation.
    Minet E; Arnould T; Michel G; Roland I; Mottet D; Raes M; Remacle J; Michiels C
    FEBS Lett; 2000 Feb; 468(1):53-8. PubMed ID: 10683440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling.
    Kasuno K; Takabuchi S; Fukuda K; Kizaka-Kondoh S; Yodoi J; Adachi T; Semenza GL; Hirota K
    J Biol Chem; 2004 Jan; 279(4):2550-8. PubMed ID: 14600153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation.
    Minet E; Michel G; Mottet D; Raes M; Michiels C
    Free Radic Biol Med; 2001 Oct; 31(7):847-55. PubMed ID: 11585703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
    Skinner HD; Zheng JZ; Fang J; Agani F; Jiang BH
    J Biol Chem; 2004 Oct; 279(44):45643-51. PubMed ID: 15337760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway.
    Roth U; Curth K; Unterman TG; Kietzmann T
    J Biol Chem; 2004 Jan; 279(4):2623-31. PubMed ID: 14612449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells.
    Zhou J; Fandrey J; Schümann J; Tiegs G; Brüne B
    Am J Physiol Cell Physiol; 2003 Feb; 284(2):C439-46. PubMed ID: 12388069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts.
    Zhang Q; Wu Y; Chau CH; Ann DK; Bertolami CN; Le AD
    J Cell Physiol; 2004 Apr; 199(1):89-97. PubMed ID: 14978738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
    Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
    Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells.
    Jung F; Haendeler J; Hoffmann J; Reissner A; Dernbach E; Zeiher AM; Dimmeler S
    Circ Res; 2002 Jul; 91(1):38-45. PubMed ID: 12114320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung.
    Yu AY; Frid MG; Shimoda LA; Wiener CM; Stenmark K; Semenza GL
    Am J Physiol; 1998 Oct; 275(4):L818-26. PubMed ID: 9755115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-inducible factor-1 and oncogenic signalling.
    Bárdos JI; Ashcroft M
    Bioessays; 2004 Mar; 26(3):262-9. PubMed ID: 14988927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nickel compounds act through phosphatidylinositol-3-kinase/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells.
    Li J; Davidson G; Huang Y; Jiang BH; Shi X; Costa M; Huang C
    Cancer Res; 2004 Jan; 64(1):94-101. PubMed ID: 14729612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.
    Hwang JT; Lee M; Jung SN; Lee HJ; Kang I; Kim SS; Ha J
    Carcinogenesis; 2004 Dec; 25(12):2497-507. PubMed ID: 15297373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
    Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
    Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS; Zheng JZ; Reed E; Jiang BH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells.
    Zhang SX; Gozal D; Sachleben LR; Rane M; Klein JB; Gozal E
    FASEB J; 2003 Sep; 17(12):1709-11. PubMed ID: 12958184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of HIF-1alpha under the influence of nitric oxide.
    Sandau KB; Fandrey J; Brüne B
    Blood; 2001 Feb; 97(4):1009-15. PubMed ID: 11159530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.